Traws Pharma Q3 EPS $(0.18) Beats $(0.20) Estimate

Benzinga · 3d ago
Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 47.06 percent increase over losses of $(0.34) per share from the same period last year.